Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1666-2022Class II

INFX-8000V. For radiographic and fluoroscopic studies and intervention

Canon Medical Systems USA, Inc. / initiated 2022-01-31 / Open, Classified / root cause: software

Canon Medical System, USA, INC. began a recall of INFX-8000V. For radiographic and fluoroscopic studies and intervention on . FDA classified it as Class II and gives the reason as "The fluoroscopic dose rate might exceed the conforming value during biplane fluoroscopy". As of , the recall status on record is Open, Classified, and MDM tags the root cause as software.

Recall record

Recall number
Z-1666-2022
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Canon Medical Systems USA, Inc.
Product
INFX-8000V. For radiographic and fluoroscopic studies and intervention.
Product code
OWB Interventional Fluoroscopic X-Ray System
Reason for recall
The fluoroscopic dose rate might exceed the conforming value during biplane fluoroscopy.
Root cause tag
software
FDA root cause
Software design
Action
Canon sent an Urgent Electronic Product Radiation Warning letter dated July 28, 2022 to customers. . Customer were informed that in the interim a temporary countermeasure will be performed until such time as the software becomes available. A representative of Canon Medical Systems USA will contact you to schedule a time to install the countermeasure and at a later date, the updated software to address the issue. For scheduling questions, please contact our InTouch team at [email protected]. For questions call 800-421-1968 or your Canon service representative at 800.521.1968.
Quantity in commerce
16 systems
Distribution
US Nationwide Distribution
Product codes and lots
Model: Alphenix i with software version 8.0, 9.0 or 9.2 and the TFP 1200C FPD.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1666-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1666-2022Class IIOngoingFDA Mandated